GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.67B
Close$
$-140.29
349.8% downside
Current Fair Value
349.8% downsideOvervalued by 349.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 1.97 |
| Outstanding Shares | 29,710,139 |
Return
| Return on Equity | -43.55% |
|---|---|
| Return on Assets | -22.09% |
| Return on Invested Capital | -16.55% |
Valuation & Multiples
| P/E Ratio | -15.43 |
|---|---|
| PEG | 5.84 |
| Price to Sales | 3.74 |
| Price to Book Ratio | 7.02 |
| Enterprise Value to Revenue | 3.92 |
| Enterprise Value to EBIT | -26.45 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$111.01 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.07
Average shareholder expectationRevenue Estimate
$122.93 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 35.41% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.51%▼ 105.75% |
|---|---|
| Total Invested | $53.92M▼ 97.53% |
| Investors Holding | 13▼ 227.00% |
ESG Score
No data
About GeneDx Holdings Corp
3 employeesSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...